Tamara Maes
Founder at ORYZON GENOMICS S.A.
Net worth: 5 M $ as of 2024-04-29
Tamara Maes active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ORYZON GENOMICS S.A. | Director/Board Member | 2000-06-01 | - |
| Founder | 2000-06-01 | - | |
| Chief Tech/Sci/R&D Officer | 2000-06-01 | 2020-11-01 | |
| Oncnosis Pharma AIE | Corporate Officer/Principal | - | - |
Mendelion Lifesciences SL
 Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Director/Board Member | - | - |
Alzheimers Drug Discovery Foundation
 Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Corporate Officer/Principal | 2015-12-31 | - |
Career history of Tamara Maes
Training of Tamara Maes
| Ghent University | Doctorate Degree |
Statistics
International
| Spain | 4 |
| Belgium | 2 |
| United States | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Industrial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Private companies | 3 |
|---|---|
| Oncnosis Pharma AIE | |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Industrial Services |
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Health Technology |
- Stock Market
- Insiders
- Tamara Maes
- Experience
